Related Experiment Video
Updated: Oct 24, 2026

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
Published on: February 14, 2018
P&T Committee review of fluconazole: an effective alternative to antifungal therapy
H C Neu1, J E Bennett, G P Bodey
1College of Physicians and Surgeons of Columbia University, New York City.
Abstract:
Fluconazole is a new antifungal agent available in both oral and parenteral formulations. According to the experts in this roundtable discussion, fluconazole represents a major clinical advance in the treatment of candidiasis and cryptococcosis in cancer patients, patients with AIDS, organ transplant recipients, and other patients at risk for opportunistic mycoses. The pharmacokinetic profile for fluconazole permits infrequent dosing and also makes it ideal for tissue site infections. Fluconazole's low toxicity gives it an advantage over currently available antifungal therapy and will permit prompt presumptive treatment of selected infections.
Related Concept Videos
Antifungal Agents
Cryptococcal Meningitis
Antiprotozoal Agents
Candidiasis
Inhibitors of Viral Protein Synthesis
Anthelminthic Agents

